Nexstim offers targeted and effective therapies and diagnostics for challenging brain diseases and disorders. Our technology is solidly grounded in scientific and clinical research. We closely collaborate with key opinion leaders who, like us, believe noninvasive brain stimulation harnesses the brain's own healing power—neuroplasticity. Nexstim is helping patients—and their families—get back the life they feared they had lost.
Nexstim Plc provides an update on the pilot study in chronic pain treatment at Helsinki University Hospital
Nexstim Continues to Report Very Promising MDD Treatment Outcomes with Remission Rate Greater than 50%
Impressive New Study Results Suggest Potential New Therapeutic Use for Nexstim SmartFocus® nTMS in Postsurgical Rehabilitation of Paresis
Nexstim Plc provides encouraging results of the initial pilot study in severe depression at Kuopio University Hospital
Nexstim Secures Business Finland Funding for the Development of Accelerated iTBS Protocols
Nexstim Plc provides an update on the pilot study in severe depression at Kuopio University Hospital
Nexstim Plc signs a purchase agreement worth EUR 0.9 million to develop and deliver two prototype systems for a research project